logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Avanir Pharmaceuticals


USPTO Granted Patents = 38

% Expired Patents = 71.1



Trademarks = 5

Forward Citations = 595

Loading Chart...
Loading Chart...

29 inventors (with patents filed for the assignee):

goldMedal Jagadish C Sircar (28 out of 36 patents)

silverMedal Wenbin Ying (19 out of 54 patents)

bronzeMedal Sunil Kumar K C (14 out of 23 patents)

4.  Robert Z Florkiewicz (13 out of 25 patents)

5.  Federico C A Gaeta (13 out of 24 patents)

6.  Jerry Anchin (13 out of 14 patents)

7.  Andrew J Baird (13 out of 36 patents)

8.  Mark L Richards (9 out of 11 patents)

9.  Laura E Pope (6 out of 8 patents)

10.  Michael W Major (5 out of 7 patents)

11.  Michael G Campbell (5 out of 15 patents)

12.  Sunil Kumar Kc (4 out of 125 patents)

13.  Matt Johnson (4 out of 4 patents)

14.  Cunxiang Zhao (4 out of 4 patents)

15.  Weihua Meng (4 out of 4 patents)


38 patents:

1. 12291505 - Methods for the synthesis of deuterated dextromethorphan (2025-05-06),
2. 11845731 - Methods for the synthesis of deuterated dextromethorphan (2023-12-19),
3. 10865187 - Methods for the synthesis of deuterated dextromethorphan (2020-12-15),
4. 10730841 - Methods for the synthesis of deuterated dextromethorphan (2020-08-04),
5. 8227484 - Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders (2012-07-24),
6. 7732146 - Method for screening an agent that modulates activity of macrophage migration inhibitory factor (2010-06-08),
7. 7659282 - Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders (2010-02-09),
8. 7514225 - Method for screening an agent that modulates activity of macrophage migration inhibitory factor (2009-04-07),
9. 7432374 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same (2008-10-07),
10. 7375118 - Phenyl-indole compounds for modulating IgE and Inhibiting cellular proliferation (2008-05-20),
11. 7365200 - Thienopyridinone derivatives as macrophage migration inhibitory factor inhibitors (2008-04-29),
12. 7361760 - Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases (2008-04-22),
13. 7312221 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same (2007-12-25),
14. 7312220 - Inhibitors of macrophage migration inhibitory factor and methods for identifying the same (2007-12-25),
15. 7282518 - Benzimidazole compounds for modulating IgE and inhibiting cellular proliferation (2007-10-16),
Avanir Pharmaceuticals is a pharmaceutical company specializing in the development of innovative therapies for central nervous system disorders. With a focus on neurological conditions, Avanir strives to improve the lives of patients through cutting-edge research, advanced technology, and compassionate care. Their commitment to addressing unmet medical needs has made them a trusted provider of effective treatment options.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

Avanir Pharmaceuticals
38 Patents

#164 in San Diego, CA

#2,127 in California

#9,008 in US

#17,797 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Avanir Pharmaceuticals

Forward Citations = 595

29 inventors:

goldMedal Jagadish C Sircar (28 out of 36 patents)

silverMedal Wenbin Ying (19 out of 54 patents)

bronzeMedal Sunil Kumar K C (14 out of 23 patents)

4.  Robert Z Florkiewicz (13 out of 25 patents)

5.  Federico C A Gaeta (13 out of 24 patents)

Please report any incorrect information to [email protected]
Loading…